Are Poor Financial Prospects Dragging Down Medtronic plc (NYSE:MDT Stock?

With its stock downwardly xv% over the by 3 months, it is like shooting fish in a barrel to condone Medtronic (NYSE:MDT). We decided to study the company’due south financials to determine if the downtrend will continue as the long-term functioning of a company commonly dictates market outcomes. In this article, we decided to focus on Medtronic’s ROE.

Return on Equity or ROE is a exam of how effectively a visitor is growing its value and managing investors’ money. In other words, it is a profitability ratio which measures the rate of return on the majuscule provided by the company’south shareholders.

Cheque out our latest assay for Medtronic

How Do Yous Calculate Return On Disinterestedness?

formula for return on equity

Return on Disinterestedness = Net Profit (from standing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Medtronic is:

8.3% = US$iv.3b ÷ Us$52b (Based on the trailing twelve months to October 2022).

The ‘return’ is the amount earned afterward tax over the last twelve months. So, this means that for every $1 of its shareholder’southward investments, the company generates a profit of $0.08.

What Has ROE Got To Do With Earnings Growth?

We have already established that ROE serves as an efficient profit-generating gauge for a company’due south time to come earnings. Based on how much of its profits the visitor chooses to reinvest or “retain”, we are then able to evaluate a company’s future power to generate profits. Bold everything else remains unchanged, the college the ROE and turn a profit retention, the higher the growth rate of a visitor compared to companies that don’t necessarily conduct these characteristics.

Medtronic’s Earnings Growth And eight.3% ROE

On the face of information technology, Medtronic’s ROE is not much to talk about. We then compared the company’s ROE to the broader manufacture and were disappointed to see that the ROE is lower than the industry average of 12%. Thus, the depression net income growth of 4.9% seen by Medtronic over the past v years could probably exist the result of the low ROE.

We and so compared Medtronic’s cyberspace income growth with the industry and found that the company’s growth figure is lower than the average manufacture growth rate of 17% in the aforementioned period, which is a bit concerning.


Earnings growth is an of import metric to consider when valuing a stock. What investors need to determine adjacent is if the expected earnings growth, or the lack of it, is already built into the share cost. This and then helps them determine if the stock is placed for a bright or bleak future. Is MDT fairly valued? This infographic on the visitor’due south intrinsic value has everything yous need to know.

Is Medtronic Using Its Retained Earnings Effectively?

Medtronic has a three-year median payout ratio of 68% (implying that it keeps merely 32% of its profits), meaning that it pays out most of its profits to shareholders equally dividends, and as a result, the visitor has seen low earnings growth.

Additionally, Medtronic has paid dividends over a catamenia of at least 10 years, which means that the visitor’s management is adamant to pay dividends even if it means trivial to no earnings growth. Our latest analyst data shows that the futurity payout ratio of the company is expected to driblet to 51% over the adjacent three years. The fact that the company’south ROE is expected to rise to xiv% over the aforementioned catamenia is explained by the drop in the payout ratio.


Overall, we would be extremely cautious before making any decision on Medtronic. Because the company is non reinvesting much into the business organization, and given the depression ROE, information technology’southward non surprising to see the lack or absence of growth in its earnings. Having said that, looking at the current analyst estimates, nosotros found that the visitor’s earnings are expected to gain momentum. Are these analysts expectations based on the wide expectations for the manufacture, or on the company’s fundamentals? Click here to be taken to our analyst’southward forecasts page for the company.

Take feedback on this article? Concerned near the content?
Get in bear on

with united states of america direct.

Alternatively, email editorial-team (at)

This article past Simply Wall St is general in nature.
Nosotros provide commentary based on historical data and analyst forecasts merely using an unbiased methodology and our articles are non intended to exist financial advice.
It does not constitute a recommendation to purchase or sell any stock, and does not take account of your objectives, or your fiscal situation. We aim to bring you long-term focused analysis driven by central data. Note that our analysis may not gene in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in whatever stocks mentioned.

Join A Paid User Research Session

You’ll receive a
U.s.a.$30 Amazon Gift card
for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up hither